In atherosclerosis, given the indispensable role of NF-κB signaling in macrophage proinflammatory response, it is critical to reveal how NF-κB can land on its target proinflammatory genes and mediate their transcription. This evidence concerns the gene NFKB1 and atherosclerosis.